A 1-year Multi-center, Prospective, Cohort Study in Patients With Chronic Obstructive Pulmonary Disease Treated With Long-acting Bronchodilator

A 1-year Multi-center, Prospective, Cohort Study in Patients With Chronic Obstructive Pulmonary Disease Treated With Long-acting Bronchodilator

This multi-center study is designed to describe natural history of disease, treatment and health care products in physician-diagnosed COPD patients who require adding daily maintenance therapy in real world.

The study planned to enroll 550 patients in Indacaterol group and 9450 patients in non- Indacaterol group, a total of 10,000 patients. Enrollment was stopped at 2253 patients due to low recruitment in indacaterol group. Finally a total of 2229 patients were analyzed in full analysis set.

A total of 2253 patients entered into the database, of which 24 patients were exclude during the data review meetings, because they did not met the inclusion/exclusion criteria. Hence a total of 2229 patients enrolled successfully.

Inclusion Criteria:

• Willing and able to provide informed consent
• Physician-diagnosis of COPD
• COPD patients requiring long-acting bronchodilator treatment
• Patients with spirometry available at baseline

Exclusion Criteria:

• Patients who have a diagnosis of asthma.
• Patients who had been hospitalized for a COPD exacerbation in the 4 weeks prior to Visit 1.
• Current clinical diagnosis of other chronic respiratory illnesses
• Concurrent participation in a clinical trial or use of an investigational drug.
• Active malignancy or history of malignancy of any organ system
• Pregnant or nursing (lactating) women
• Women of child-bearing potential with no contraception Other protocol-defined inclusion/exclusion criteria may apply.